22 reports of this reaction
1.9% of all CAMPHOR reports
#17 most reported adverse reaction
NASOPHARYNGITIS is the #17 most commonly reported adverse reaction for CAMPHOR, manufactured by Strides Consumer LLC. There are 22 FDA adverse event reports linking CAMPHOR to NASOPHARYNGITIS. This represents approximately 1.9% of all 1,159 adverse event reports for this drug.
Patients taking CAMPHOR who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NASOPHARYNGITIS is a less commonly reported adverse event for CAMPHOR, but still significant enough to appear in the safety profile.
In addition to nasopharyngitis, the following adverse reactions have been reported for CAMPHOR:
The following drugs have also been linked to nasopharyngitis in FDA adverse event reports:
NASOPHARYNGITIS has been reported as an adverse event in 22 FDA reports for CAMPHOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
NASOPHARYNGITIS accounts for approximately 1.9% of all adverse event reports for CAMPHOR, making it a notable side effect.
If you experience nasopharyngitis while taking CAMPHOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.